To investigate this, we evaluated the in vitro response of human AD-MSCs from three donors expanded across seven passages under, non-inflamed (DMEM), acute (IFNγ-24 h) and constant (IFNγ-C) inflammatory conditions. This evidence concerns the gene IFNG and Alzheimer disease.